Search research articles
Contact Us
Filters
Showing results (31-40 of 70) with videos related to
Page
of 7
Sort By:
Acta Obstetricia Et Gynecologica Scandinavica
|
December 8, 2022
High-risk HPV testing vs liquid-based cytology for cervical cancer screening among 25- to 30-year-old women: A historical cohort study
Ohad Feldstein, Hadar Gali-Zamir, Eduardo Schejter, et al.
Chemotherapy
|
March 2, 2016
Gemcitabine-Induced Subacute Cutaneous Lupus Erythematosus: A Case Report
Masha Ben Zvi, Hananya Vaknine, Joseph Menczer, et al.
Gynecologic Oncology Reports
|
October 23, 2023
Fluorescein mapping for identification of residual satellite vulvar Paget's lesion
Allison Joyce Siegel, Malgorzata Budzynska, Brandon Oleg Litvak, et al.
Infectious Diseases in Obstetrics and Gynecology
|
August 30, 2005
Occurrence of cervical intraepithelial neoplasia in generally healthy women with exophytic vulvar condyloma acuminata
Oscar Sadan, Efi Bilevsky, Eduardo Shejter, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
February 19, 2025
Pre-operative platelet-to-lymphocyte ratio can help predict residual disease after primary debulking surgery for epithelial ovarian cancer
Ori Tal, Meirav Schmidt, Rachelli Fried, et al.
Gynecologic Oncology
|
March 26, 2005
A comparison between different postoperative treatment modalities of uterine carcinosarcoma
Joseph Menczer, Tally Levy, Benjamin Piura, et al.
Gynecologic Oncology
|
January 24, 2007
Efficacy and toxicity of weekly topotecan in recurrent epithelial ovarian and primary peritoneal cancer
Tamar Safra, Joseph Menczer, Rinat Bernstein, et al.
Cancers
|
March 28, 2026
Heterogeneity in Stage IV Ovarian Cancer: Survival Trends in Patients Presenting with Sister Mary Joseph's Nodule
Ori Tal, Andreas Schötzau, Nicolò Bizzarri, et al.
Archives of Gynecology and Obstetrics
|
February 4, 2017
A phase 1/2a, dose-escalation, safety, pharmacokinetic, and preliminary efficacy study of intraperitoneal administration of BC-819 (H19-DTA) in subjects with recurrent ovarian/peritoneal cancer
Ofer Lavie, David Edelman, Tally Levy, et al.
International Journal of Clinical and Experimental Medicine
|
November 13, 2010
Targeting diphtheria toxin and TNF alpha expression in ovarian tumors using the H19 regulatory sequences
Aya Mizrahi, Abraham Hochberg, Smadar Amiur, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 70) with videos related to
Sort By:
Page
of 7
Acta Obstetricia Et Gynecologica Scandinavica
|
December 8, 2022
High-risk HPV testing vs liquid-based cytology for cervical cancer screening among 25- to 30-year-old women: A historical cohort study
Ohad Feldstein, Hadar Gali-Zamir, Eduardo Schejter, et al.
Chemotherapy
|
March 2, 2016
Gemcitabine-Induced Subacute Cutaneous Lupus Erythematosus: A Case Report
Masha Ben Zvi, Hananya Vaknine, Joseph Menczer, et al.
Gynecologic Oncology Reports
|
October 23, 2023
Fluorescein mapping for identification of residual satellite vulvar Paget's lesion
Allison Joyce Siegel, Malgorzata Budzynska, Brandon Oleg Litvak, et al.
Infectious Diseases in Obstetrics and Gynecology
|
August 30, 2005
Occurrence of cervical intraepithelial neoplasia in generally healthy women with exophytic vulvar condyloma acuminata
Oscar Sadan, Efi Bilevsky, Eduardo Shejter, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
February 19, 2025
Pre-operative platelet-to-lymphocyte ratio can help predict residual disease after primary debulking surgery for epithelial ovarian cancer
Ori Tal, Meirav Schmidt, Rachelli Fried, et al.
Gynecologic Oncology
|
March 26, 2005
A comparison between different postoperative treatment modalities of uterine carcinosarcoma
Joseph Menczer, Tally Levy, Benjamin Piura, et al.
Gynecologic Oncology
|
January 24, 2007
Efficacy and toxicity of weekly topotecan in recurrent epithelial ovarian and primary peritoneal cancer
Tamar Safra, Joseph Menczer, Rinat Bernstein, et al.
Cancers
|
March 28, 2026
Heterogeneity in Stage IV Ovarian Cancer: Survival Trends in Patients Presenting with Sister Mary Joseph's Nodule
Ori Tal, Andreas Schötzau, Nicolò Bizzarri, et al.
Archives of Gynecology and Obstetrics
|
February 4, 2017
A phase 1/2a, dose-escalation, safety, pharmacokinetic, and preliminary efficacy study of intraperitoneal administration of BC-819 (H19-DTA) in subjects with recurrent ovarian/peritoneal cancer
Ofer Lavie, David Edelman, Tally Levy, et al.
International Journal of Clinical and Experimental Medicine
|
November 13, 2010
Targeting diphtheria toxin and TNF alpha expression in ovarian tumors using the H19 regulatory sequences
Aya Mizrahi, Abraham Hochberg, Smadar Amiur, et al.
Page
of 7